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Abstract
A study was undertaken to evaluate the efficacy of an adenoviral construct expressing the murine interferon- (IFN-) transgene
(Ad:IFN-) against herpes simplex virus type 1 (HSV-1) infection in a primary trigeminal ganglion (TG) cell culture. The transduction
efficiency ranged from 0.2 to 11.0% depending on the multiplicity of infection (m.o.i.) of the adenoviral vector (0.5–50.0). Moreover,
neurons were the main target of the adenoviral transduction. TG cultures transduced with Ad:IFN- displayed up to a 19-fold reduction in
viral titers compared with cells transduced with an Ad:Null or nontransduced TG culture controls. Transduction with Ad:IFN- up-regulated
two critical antiviral genes, double-stranded RNA-dependent protein kinase R (PKR) and 2,5-oligoadenylate synthetase (OAS). The
absence of PKR or RNase L (downstream effector molecule of OAS) attenuated Ad:IFN- efficacy against HSV-1 replication, implicating
a critical role for PKR and OAS/RNase systems in the establishment of IFN-induced resistance against HSV-1 in TG cells.
© 2003 Elsevier Science (USA). All rights reserved.
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Introduction
Herpes simplex virus type 1 (HSV-1) corneal infection
represents a significant clinical problem. The virus enters the
host by direct inoculation of mucous membranes, where it
establishes a lytic infection of epithelial cells (Krummenacher
et al., 1998). During the primary infection, HSV-1 is able to
spread to the neurons of the sensory ganglion [e.g., trigeminal
ganglion (TG)] and establish a latent infection (Cook and
Stevens, 1973). It is within the peripheral nervous system that
the virus must overcome immune detection, evade innate im-
munity, and alter expression of lytic genes in establishing a
life-long persistent infection capable of reactivation either
spontaneously or following environmental cues.
Type I interferons (IFN-/) are crucial antiviral pro-
teins induced in the early innate immune response to viral
infection. These regulatory cytokines antagonize synthesis
of viral mRNA and translation of viral proteins (Pestka et
al., 1987). Type I IFNs not only enhance immunologic
targeting of virally infected cells by activating natural killer
cell cytotoxicity and stimulating TH1 cell development
(Gutterman, 1994), but they also induce the synthesis of
intracellular proteins that directly inhibit viral replication.
IFN-responsive, antiviral proteins include double-stranded
RNA-dependent protein kinase R (PKR) and 2,5-oligoad-
enylate synthetases (OAS) that function through RNase L
(Foster, 1997). OAS is a group of enzymes that catalyze the
synthesis of 5-triphosphorylated, 2 to 5 linked oligoad-
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enylates, typically three or four nucleotides in length (2-5A)
(Kerr and Brown, 1978). The 2–5A molecules bind with
high affinity to RNase L, an endoribonuclease that catalyzes
the cleavage of single-stranded mRNA and rRNA, thereby
leading to inhibition of protein synthesis (Silverman, 1997).
Relative to HSV-1 infection, disruption of the RNase L gene
has been found to increase the susceptibility of mice to
HSV-1 keratitis and viral-mediated mortality through an
ill-defined mechanism (Zheng et al., 2001). Another IFN-
responsive protein, PKR, is a serine/threonine kinase that is
normally inactive, but is activated by binding to dsRNA or
other polyanions (Meurs et al., 1990; Katze et al., 1991).
Activated PKR suppresses translation initiation via phosphor-
ylation of eukaryotic initiation factor 2 (Meurs et al., 1992) and
acts as a signal transducer for proinflammatory gene expres-
sion (Williams, 2001). Recent results demonstrate that the
absence of PKR greatly increases HSV-1 replication in mouse
embryo fibroblasts (Khabar et al., 2000).
The present study was undertaken to test the hypothesis
that an adenoviral vector that contains the murine IFN-
transgene (Ad:IFN-) is proficient in delivery and expres-
sion of the transgene to primary TG cell cultures. Adeno-
viral vectors are powerful tools in vivo because of the wide
range of cells and tissues they can transduce with high
efficiency. The use of such vectors would provide efficient
means to deliver IFN- to the TG, which might subse-
quently interfere with reactivation in vivo. The present
study aimed to test whether RNase L or PKR plays a role in
mediating the antiviral effects of IFN-. The use of primary
TG cell cultures is advantageous over the use of cell lines.
Specifically, the TG is the natural site in the establishment
of latency during acute infection as well as reactivation
from latency in quiescent HSV-1 infection. In addition, cell
lines are transformed cells typically undergoing major
changes in their pro- and antiapoptotic pathways (Farassati
et al., 2001; Malkinson et al., 1997; Roninson, 2002). In
some instances, these same pathways are involved as a
defense against viral infection. Both RNase L and PKR
control cell growth, cell differentiation, viral clearance, and
apoptosis (Castelli et al., 1998; Gil et al., 2002; Zhou et
al.,1997). Therefore, IFN-signaling is more likely to be
altered in these cell lines as compared to primary cells. The
present study found primary TG cells transduced with Ad:
IFN- secreted biologically active IFN and repressed viral
replication in a dose-dependent fashion that was dependent
on PKR and to a lesser extent, OAS/RNase L.
Results
Transduction efficiency and production of IFN-
A replication-deficient adenovirus construct expressing
green fluorescent protein (Ad:GFP) was employed to deter-
mine the efficacy of transduction. Transduction of primary
TG cells resulted in green fluorescence expressed in cul-
tured cells in a dose-dependent fashion (Fig. 1A). TG cells
represent a heterogeneous population composed of neurons,
fibroblasts, and supporting cells (e.g., Schwann cells).
Based on morphological characteristics of the neurons (i.e.,
large, single cells that contain a darkly pigmented cyto-
plasm and a prominent nucleus), the cells most receptive to
transduction (m.o.i.  5.0) were most likely neurons (Fig.
1B). To validate this observation, Ad:GFP transduced TG
cell cultures were fixed and stained for neuron-specific
enolase. A disproportionably high number of cells that were
positive for GFP costained with neuron-specific enolase
(Fig. 2). In contrast, fibroblasts and most of the supporting
cells that normally predominate these cultures expressed
low to undetectable levels of GFP. However, upon increas-
ing the m.o.i. (m.o.i.  50.0) of the Ad:GFP, a more
heterogeneous population of cells expressed GFP (data not
shown). The results suggested that Ad:GFP preferentially
transduced neuronal cells when a low m.o.i. was used. On
average, each primary TG cell culture contains 341  29
neurons/well with each well containing between 5 and 10
104 cells at the time of transduction.
Since targeted cells were efficiently transduced with the
adenoviral construct expressing the reporter gene product
GFP, cells were subsequently targeted using the replicative-
deficient adenoviral construct containing the murine IFN-
gene. Cells that were transduced with Ad:IFN- secreted
biologically active IFN- in a dose-dependent fashion (Ta-
ble 1). Nontransduced cells or cells transduced with the
Ad:Null construct secreted no measurable level of biologi-
cally active IFN-.
Ad:IFN- inhibits HSV-1 replication
To determine the efficacy of Ad:IFN- in antagonizing
HSV-1 replication in primary TG cell cultures, dissociated
TG cells were transduced with Ad:IFN- and assayed for
resistance to the highly neurovirulent strain of HSV-1,
McKrae. Virus titers were significantly less in the Ad:IFN-
transduced cells compared with the nontransduced cells or
cells transduced with Ad:Null vector (Fig. 3A). The reduc-
tion in infectious viral titer was dependent on the m.o.i. of
the Ad:IFN- used for transduction (Fig. 3B). In the pres-
ence of neutralizing antibody to IFN-, no antiviral activity
was observed in the Ad:IFN- transduced cultures, suggest-
ing the IFN- must be secreted to confer resistance to
HSV-1 infection (data not shown).
Absence of a functional PKR or OAS/RNase L pathway
attenuates the antiviral state of the Ad:IFN- construct
In an attempt to identify contributing factors to the an-
tiviral nature of the IFN- transgene, levels of two critical
IFN responsive, antiviral genes (PKR and OAS) were as-
sessed in the transduced TG cells using real-time PCR. PKR
and OAS transcript levels were 13- and 26-fold higher, respec-
tively, in the TG cultures transduced with Ad:IFN- compared
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to the Ad:Null- or nontransduced controls (Fig. 4). To delin-
eate the potential relevance of the PKR and OAS/RNase L
pathways in the establishment of an antiviral state following
Ad:IFN- transduction, dissociated TG cells from mice defi-
cient in the RNase L enzyme (RL/) or in PKR (PKR/)
were employed. RNase L is the downstream effector molecule
induced following OAS activation, and its deletion produces a
functional knockout of the OAS pathway (Zhou et al., 1997).
There was no difference in the viral titers recovered from
wild-type (wt), PKR/, and RL/ in the nontransduced or
Ad:Null-transduced TG cell cultures (Fig. 5A). Although
transduction with Ad:IFN- reduced the viral yield from the
TG cell cultures taken from the knockouts or wild-type mice,
the sensitivity of the knockouts to IFN was dependent on the
m.o.i. of HSV-1. At an m.o.i.  1.0 only the absence of PKR
adversely affected the Ad:IFN- efficacy compared to the wt
or the RL/ TG cell cultures (Fig. 5A). Specifically, in the
wt or RL/ TG cultures, Ad:IFN- transduction reduced the
viral titer 17-fold, whereas the reduction in PKR/ TG cell
cultures was only seven-fold (Fig. 5D). However, at a lower
m.o.i. (m.o.i. 0.1 or 0.02) the absence of either PKR or OAS
adversely affected the Ad:IFN- efficacy (Figs. 5B and C).
Specifically, at an m.o.i. of 0.02, in the wt cultures, Ad:IFN-
transduction reduced the viral yield 129-fold, whereas the
reduction in RNase L/ cultures was 25-fold and the PKR
cultures was only 15-fold (Fig. 5D).
Discussion
The present study demonstrates the feasibility of gene
transfer using a replication-deficient, recombinant adenovi-
Fig. 1. Transduction of mouse trigeminal ganglion cell cultures. (A) TG cells isolated from ICR mice were plated in 24-well microtiter plates in 1 ml of TG
media. After 7 days of culturing, the medium was removed and Ad:GFP was added at the indicated m.o.i. Forty-eight hours posttransduction, three random
fields were counted for total and GFP expressing cells by fluorescence microscopy (Zeiss Axiovert 135) under  200 magnifications. The graph represents
the percentage of cells expressing GFP (number of cells expressing GFP/total number of cells in the field). The experiment was conducted twice, each in
triplicate. (B) Representative photomicrographs of a neuron in a TG cell culture 48 h after transduction with Ad:GFP at an m.o.i. of 5, as seen when
illuminated with visible light (right panel) or the 360- to 400-nm spectrum of light (left panel).
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ral vector to deliver an exogenous murine IFN- transgene
to primary TG cell cultures. Adenoviral transduction in the
peripheral nervous system is rarely investigated. Previous
data showed that adenoviral vectors injected in the posterior
horn of the spinal cord could deliver genes to motor neurons
and to a lesser degree, other types of neurons and supporting
Fig. 2. Adenoviral vectors preferentially transduce neurons in primary TG cell cultures. Dissociated TG cells isolated from ICR mice were grown in culture
on coverslips and were transduced with Ad:GFP (m.o.i.  5.0) 7 days after establishment of the culture. Two days later, the cells where fixed and stained
as described under materials and methods. GFP expression in Ad:GFP transduced cells (A) colocalized with neuron-specific enolase (B); nuclei were
counterstained with DAPI (C). (D) represents the merge image.
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cells (Huber et al., 2000). The present study demonstrates
that adenoviral vector is a successful means to deliver de-
sired genes preferentially to the neurons in the TG in a
dose-dependent fashion. One possible mechanism for this
tropism is the selective presence of the Coxsackie adenovi-
rus receptor (CAR) on neuronal cell surfaces but not other
supporting cells. Adenovirus binds to CAR to successfully
transduce neuronal cells in vitro (Caillaud et al., 1993).
Previous data demonstrated that CAR was primarily located
on neurons derived from the CNS and that glia and other
supporting cells did not express the receptor on their surface
(Soudais et al., 2001). However, the results of this study
show that if the m.o.i. of the adenoviral vector is increased,
other cell populations in the TG culture can be transduced.
It is likely that at a relatively high m.o.i., the adenoviral
vector loses cellular specificity through utilizing less effi-
cient receptors to enter the cell (Chiu et al., 2001; Nemerow
and Stewart, 1999).
IFN- has previously been found to up-regulate OAS in
primary neuronal cultures through ISGF3 (Massa et al.,
1999). In the present study using primary TG cell cultures,
the two prominent antiviral, IFN-regulatory genes, OAS and
PKR, were elevated 13-fold and 26-fold, respectively, fol-
lowing transduction with the Ad:IFN- vector. In contrast
with previous data using embryonic fibroblast cell lines
(Al-Khatib et al., 2002), the present study found the absence
of either the RNase L or the PKR pathway did not enhance
HSV-1 replication. The disparity between these results may
reside with those pathways modified in the cell lines con-
trolling cell growth and apoptosis that ultimately mediate
one form of resistance to viral infection (Farassati et al.,
2001; Roninson, 2002). The absence of either PKR or
RNase L in primary cells is compensated by the presence of
other intact antiviral pathways as previously suggested
(Zhou et al., 1999) with a number of candidate genes iden-
tified (de Veer et al., 2001). Taken together, the use of
primary cell cultures provides a more credible system to
illustrate the complexities and redundancies associated with
the antiviral state elicited by type I IFNs.
Lowering the m.o.i. of HSV-1 resulted in an m.o.i.-
dependent decrease in viral yield in the wild-type, RNase
L/, and PKR/ cells. However, the importance of
PKR or OAS/RNase L systems in mediating IFN antiviral
action became more evident with a lower viral inoculum.
Specifically, the absence of either PKR or RNase L ad-
versely reduced the antiviral efficacy of IFN- when a low
m.o.i. of HSV-1 was used (m.o.i.  0.02). However at
higher m.o.i. (m.o.i.  1.0), only the absence of PKR
proved detrimental to IFN action. Consistent with our re-
sults, other investigators have reported IFN-induced antivi-
ral pathways become more critical and their absence be-
comes more evident when changing the concentration of
IFN exposure or the virus used to infect the IFN-treated
cells (Der and Lau, 1995; Zhou et al., 1997; Stojdl et al.,
2000).
ICP34.5 is a 1 HSV viral protein that activates the
endogenous cellular protein phosphatase 1 (PP1) to
counter the effects of activated PKR (He et al., 1997; Leib
et al., 2000). Furthermore, HSV also encodes Us11 (a 2
protein) that inhibits PKR activity (Poppers et al., 2000) by
preventing a conformational change normally induced by
PACT, a protein activator of PKR (Peters et al., 2002).
Since Us11 is an abundant tegument protein brought into
the cells upon infection, it may act early to block phosphor-
ylation of eIF2 (Leib, 2002; Poppers et al., 2000). On yet
another level, HSV-1 reportedly blocks the JAK1/STAT1
signaling cascade by preventing phosphorylation of STAT1
and thus preventing the accumulation of ISGF3 and subse-
quent induction of IFN stimulatory genes (Yokota et al.,
2001). In fact, HSV infection decreases the level of 2-5A
synthetase mRNA in IFN--treated cells (Taylor et al.,
1995). In addition, HSV-1 infection activates ppp(A2p)nA
system in interferon-treated cells, resulting in accumulation
of ppp(A2p)2A and ppp(A2p)3A species. These com-
pounds are only weak activators of the ppp(A2p)nA-de-
pendent RNase and under appropriate conditions are capa-
ble of inhibiting the activation of this RNase by authentic
ppp(A2p)nA (Cayley et al., 1982, 1984). These findings
illustrate the diverse strategies HSV-1 has developed to
counter PKR as well as OAS pathways.
Multiple, unique, as well as redundant pathways likely
evolved by the host upon encountering HSV-1 and the viral
strategies for neutralizing host defenses (Stark et al., 1998).
The redundancy in the antiviral state of Ad:IFN--trans-
duced cells was evident in the present TG cell-culture model
using a relatively high m.o.i. of HSV-1. In the absence of
PKR, cells transduced with the Ad:IFN- were still resistant
to HSV-1 infection compared to the control-transduced
cells, although the level of resistance had dropped appre-
ciably. We interpret these results to suggest that while the
PKR pathway is central to controlling HSV-1, additional
IFN-inducible pathways are also involved, evident at the
Table 1
Cells transduced with Ad:IFN- secrete biologically active IFN-a




50 100  29
5 20  4.5
0.5 1.5  0.6
0 0.0  0.0
Ad:Null (m.o.i.  5) 0.0  0.0
a ICR Mouse dissociated TGs were plated at a density of 8  104
(equivalent to 1 TG) in 24-well plates. After 7 days in culture, the media
was removed and Ad:IFN- was added at the designated m.o.i. Ad:Null
(viral vector control) was used to transduce cultures as well. Nontrans-
duced cultures are indicated as m.o.i.  0. Thirty-six hours posttransduc-
tion, the supernatant was collected and the concentration of IFN- was
measured by plaque reduction assay using vesicular stomatitis virus. Re-
sults are representative of two independent experiments (n  3/group/
experiment). The level of detection is 1.0 units of IFN/ml.
b Numbers represent the concentration of IFN- expressed as IU/ml 
SEM.
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higher m.o.i. of HSV-1. At the lower level of infection
(m.o.i. 0.02–0.1), it would appear that OAS/RNase L and
PKR are the prominent anti-HSV-1 pathways induced by
IFN- in the TG cells. Consequently, within the confines of
our experimental model it would appear that a threshold of
virus or viral-derived proteins must be achieved to antago-
nize the antiviral effects of OAS and PKR. For HSV-1, the
level required must be between 0.1 and 1.0 PFU/cell. At or
above the level of 1.0 PFU/cell, additional IFN-inducible
pathways independent of OAS or PKR appear to be func-
tionally active in hindering HSV-1 replication. The charac-
terization of the relative contributions of these IFN stimu-
latory pathways will be a challenge due to the large number
of IFN-regulated genes (Der et al., 1998). However, only by
investigating the specific functions of the proteins encoded
in the interferon-stimulated genes will the biological effects
of IFNs be understood. Elucidating viral and enzyme-spe-
cific mechanisms that mediate the antiviral actions of IFN
may also facilitate the design of additional therapeutic strat-
egies to overcome viral pathogenesis.
Materials and methods
Mice, cells, and viruses
Female 8- to 12- week-old ICR mice (Harlan Sprague–
Dawley, Indianapolis, IN) as well as C57BL/6 mice (Jack-
son Labs, Bar Harbor, ME), RNase L-null mice (Zhou et al.,
1997), and PKR-null mice (Yang et al., 1995) were used in
Fig. 3. Mouse TG cell cultures transduced with Ad:IFN- show resistance to HSV-1 infection. (A) Primary TG cells isolated from ICR mice were transduced
with the Ad:IFN- vector (hatched column) or the Ad:Null vector (white column) at an m.o.i.  5. The black column represents the nontransduced group.
After 36 h the medium was removed and the cells were then infected with HSV-1 (m.o.i.  1.0). Viral titers (PFU/ml) were measured 24 h postinfection
(p.i.). Results are representative of three experiments (n  3/group/experiment) (*P  0.05 comparing Ad:IFN--transduced group with Ad:Null-transduced
or to nontransduced groups). (B) Primary TG cells were transduced with Ad:IFN- at the indicated m.o.i. Cells were subsequently infected with HSV-1 at
an m.o.i. of 1 and the viral titer was measured 24 h p.i. Results are the average of two experiments each conducted in triplicate. *P  0.05 comparing the
viral titers between cultures transduced at the designated m.o.i. to nontransduced cultures.
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these experiments. All animals were handled in accordance
with the National Institutes of Health guidelines on the care
and use of laboratory animals (Publication no. 85-23, re-
vised 1996). All procedures were approved by the Univer-
sity of Oklahoma Health Sciences Center institutional ani-
mal care and use committee. L929 and Vero cells were
obtained from the American Type Culture Collection
(ATCC, Manassas, VA) and propagated in DMEM or
RPMI-1640 medium, respectively, containing 0.375% HCO3
supplemented with 10% fetal bovine serum (FBS) and antibi-
otic/antimycotic solution (GIBCO, Gaithersburg, MD) (re-
ferred to as complete DMEM or RPMI, respectively).
The viruses used in this study were McKrae strain of
HSV-1 and vesicular stomatitis virus (VSV) (a gift from Dr.
Robert Fleischmann, UTMB). HSV-1 and VSV were prop-
agated in Vero cells and aliquots were stored at -80°C. The
three following replication-defective adenoviral vectors
(E1–E3) were used in this study: Ad:GFP, Ad:IFN-,
and Ad:Null (empty vector). The adenovirus vectors were
constructed as previously described (Al-Khatib et al., 2002).
Fig. 4. Ad:IFN- transduction up-regulates PKR and OAS. Primary TG
cells isolated from ICR mice were transduced with either Ad:IFN-
(hatched column) or Ad:Null (white column) at an m.o.i. of 5. A third
group was left nontransduced (black column). RNA isolation and reverse
transcription was performed with the cells 36 h posttransduction. cDNA
templates were amplified using primers specific for OAS and PKR via real
time PCR. The data are expressed in terms of relative value representing
the relative gene transcript level normalized to the GAPDH level. Results
are the average of three independent experiments (n  2/group/experi-
ment). *P  0.01 comparing Ad:IFN--transduced group with Ad:Null-
transduced or nontransduced groups.
Fig. 5. The absence of a functional PKR or OAS pathway attenuates the antiviral state of the Ad:IFN- construct. TG were obtained from wild-type C57BL/6,
PKR/, and RL/ mice. Dissociated TG cells were plated and 7 days later, the media were removed and either Ad:IFN- or Ad:Null was added to the
cultures at an m.o.i. of 5. A third group was left nontransduced. Thirty-six hours later, the cultures were infected with HSV-1 at an m.o.i. of 1.0 (A), 0.1 (B),
or 0.02 (C), and viral titers were measured 24 h p.i. Results are an average of two independent experiments (n  3 per group per experiment). (*P  0.01
comparing Ad:IFN--transduced group with Ad:Null-transduced or to nontransduced groups). (D) Data represented as the fold-reduction in viral titer
observed following transduction with Ad:IFN- relative to Ad:Null-transduced cells.
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The adenoviral vectors were all propagated in E293 cells
(ATCC) and the E1-complementing cell line under the fol-
lowing conditions: complete DMEM, 37°C, 5% CO2, and
95% humidity.
Establishment of TG cell cultures
TG cell cultures were prepared according to a modified
version of the protocol described by Moriya et al. (1994).
TG cells were cultured in complete DMEM medium with 10
ng of nerve growth factor 2.5s (Collaborative Biomedical
Products, Bedford, MA) per milliliter (TG medium). TGs
were aseptically removed from mice and placed in TG
medium on ice. TGs were pooled in 1.5 ml of calcium- and
magnesium-free Hank’s balanced saline solution containing
collagenase type XI (1 mg/ml; Sigma Chemical Co., St.
Louis, MO) and collagenase type IV (1 mg/ml; Sigma) and
incubated at 37°C for 75 to 90 min. To facilitate dissocia-
tion, ganglia were triturated every 15 min with a 1-ml
serological pipette. Next, 8.5 ml of TG medium was added
to the dissociated cells, which were then pelleted by cen-
trifugation (4°C, 5 min, 200 g), and the collagenase-con-
taining supernatant was discarded. The cells were rinsed
twice with DMEM medium and finally resuspended in TG
medium. The cells were distributed into two 24-well culture
plates (1 ml of cell suspension per well) which had been thin
coated with rat tail collagen type I (50 mg/ml; Collaborative
Biomedical Products) and recombinant mouse laminin (2.5
mg/ml; Collaborative Biomedical Products) according to
the vendor’s instructions. Cultures were incubated in a 37°C
tissue culture incubator (5% CO2, 95% humidity).
Immunocytochemistry
Dissociated TG cells obtained from ICR mice were
grown in culture on coverslips coated with laminin and
collagen. Cells were transduced with Ad:GFP (m.o.i.  5)
7 days after establishment of the culture. Two days follow-
ing transduction, cells were fixed for 30 min in 3% para-
formaldehyde in phosphate-buffered saline (PBS) contain-
ing 0.1% Triton X-100 (pH 7.5) and then rinsed three times
with 1.0 ml of PBS containing 0.1% Triton X-100 (pH 7.5).
Nonspecific binding sites were blocked by 10% normal goat
serum for 30 min at room temperature. Cells were incubated
overnight with polyclonal anti-neuron-specific enolase an-
tibody (Chemicon, Temecula, CA) (1:100 dilution) in PBS
(pH 7.5) containing 1% normal goat serum at 4°C. Follow-
ing the overnight incubation, the cells were then rinsed three
times with 1.0 ml of PBS containing 0.1% Triton X (pH
7.5). Subsequently, the cells were incubated with Texas red
conjugated goat anti-rabbit IgG (Vector Laboratories, Bur-
lingame, CA) (1:200 dilution) in PBS (pH 7.5) containing
10% normal goat serum for 1 h and washed three times for
5 min each with PBS (pH 7.5). The cells were then mounted
and nuclei were counterstained with DAPI (Vector Labora-
tories). Flourescently labeled cells were viewed using a
Nikon E800 fluorescent microscope. Cells treated without
primary antibody served as controls and were unlabeled. All
the steps of fixation and staining were done in a dark room
to reduce bleaching of GFP.
Transduction studies
Dissociated TG cells were plated at a density of 4  104
cells/ml (1/2 TG) in 24-well plates. At day 7 postplating, the
medium was removed and either the Ad:IFN- or the Ad:
Null vector was added at the indicated m.o.i. A third group
was left nontransduced as a negative control. Twenty-four
hours posttransduction, the medium was collected and
HSV-1 was added at the indicated m.o.i. The medium was
replaced with HSV-1-free medium 1 h postinfection (p.i.).
Twenty four hours p.i., cells were lysed by rapid freeze-
thawing and viral titers were determined in duplicate by
plaque assay using Vero cells. Experiments were carried out
three times, each time in triplicate.
Determination of IFN- concentration
Collected supernatants from transfected cell cultures
were clarified by centrifugation (10,000 g, 6 min). L929
cells were incubated for 24 h with serial dilutions of super-
natants and subsequently infected with VSV at an m.o.i. 
0.05. When the cytopathic effect in the control wells was
maximal (between 32 and 36 h p.i), plates were stained with
Crystal violet. In each assay, standards with recombinant
murine IFN- (PBL Biomedical Laboratories, New Bruns-
wick, NJ) were employed. The standards themselves were
calibrated against WHO international standard IFN- (Bra-
ton Biotech, Inc., Gaithersburg, MD). Fifty percent inhibi-
tion of cytopathic effect was equivalent to 1 IU/ml for
IFN-. The incubation of the supernatant with anti-mouse
(500 neutralizing units) IFN- antibody (PBL Biomedical
Laboratories) antibody at the time of transduction com-
pletely neutralized the protective effect.
Reverse transcription
TG culture cells were transduced (m.o.i.  5.0) with
either the Ad:IFN- or the Ad:Null vector. A third control
group was not transduced. RNA was harvested 36 h follow-
ing transduction with the adenoviral construct. RNA was
extracted in Ultraspect RNA isolation reagent (Biotecx Inc.,
Houston, TX). First-strand cDNA was synthesized using
avian myoblastosis virus reverse transcriptase (Promega,
Madison, WI).
Real-time PCR
Real-time PCR using the iCycler (Bio-Rad, Hercules,
CA) was used to quantify cellular gene expression. SYBR
Green (Molecular Probes, Eugene, OR) was used as the
intercalating flourophore at a final dilution of 1:100,000.
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Primers with the following sequences were used in these
experiments:
GAPDH (3 mM MgCl2) F: 5-GAATCTACTGGCGTCTTCACC-3
R: 5-GTCATGAGCCCTTCCACGATGC-3
PKR (4 mM MgCl2) F: 5-GGAAAATCCCGAACAAGGAG-3
R: 5-CCCAAAGCAAAGATGTCCAC-3
OAS1a (4 mM MgCl2) F: 5-ATTACCTCCTTCCCGACACC-3
R: 5-CAAACTCCACCTCCTGATGC-3
The MgCl2 concentration is indicated next to the primer
pair above. A melting curve showed only one peak with no
existing primer-dimer product. To confirm the absence of
primer dimers, 1% agarose gel analysis verified the ampli-
fication of one product of the predicted size with no primer-
dimer bands. All reactions were run with 35 cycles at 95° C
(30 s), followed by 60°C (50 s). Targeted gene expression
data were analyzed quantitatively using the comparative CT
method. For each gene the threshold at which product was
detected (10 standard deviations above the background sig-
nal) was compared to the endogenous (GAPDH) control.
Prior to commencing studies, the comparative CT method
was validated by ensuring that the efficiencies of both the
target gene and the GAPDH primers were approximately
equal. Results were calculated as CT, i.e., the difference
between the gene of interest and GAPDH mean thresholds
and expressed in relative values calculated as previously
described (Harle et al., 2002). Oligonucleotide primers used
to detect OAS expression were targeted to that species
encoding for a 43-kDa protein (Coccia et al., 1990).
Statistics
One-way analysis of variance (ANOVA) and Tukey’s
t-test were used to determine significant (P  0.05) differ-
ences among the Ad:IFN--, Ad:Null-, and nontreated
groups relative to IFN- production, viral load, and cellular
gene expression, using the Statistica program (Stat soft,
Tulsa, OK).
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